News and Announcements
YPB Receives Order from Bank of Thailand
- Published March 09, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Brand Protection and Customer Engagement solutions company YPB Group Ltd (ASX: YPB) is pleased to announce that it has received an order to supply Forensic Imaging equipment to the Bank of Thailand.
KEY TAKEAWAYS:
- YPB has received an order to supply forensic equipment to The Bank of Thailand.
- Order demonstrates YPB’s growing presence in the Asian anti-counterfeit market.
The Bank of Thailand is headquartered in Bangkok, Thailand, and is Thailand’s Central or Reserve Bank. The Bank of Thailand is responsible for currency printing, control and anti-counterfeit measures for the Thai Banking System.
This Builds on YPB’s relationship with The Bank of Thailand where the technology was previously used in the Thai 100 Baht note resulting in production of over 30 million units.
John Houston, Executive Chairman of YPB Limited, said: “We are honoured to be extending our relationship with The Bank of Thailand. It highlights the importance of Forensic Equipment in a rapidly growing Asian Market and the Thai Government’s commitment to fight counterfeiting.
Governments throughout Asia are realising the burden and loss of revenue that counterfeit and the black economy place on developing economies and YPB’s solutions certainly have a valuable role in protection”.
YPB Group (ASX: YPB) is a pioneer in advanced brand protection solutions. Listed on the Australian Securities Exchange, YPB is expanding its global footprint with an established presence in Australia, China, Thailand, USA and Mexico.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
